The DOI matches its Crossref record.
Transit of pharmaceutical dosage forms through the small intestine.
Open accessAbstract
The gastrointestinal transit of pharmaceutical dosage forms has been measured in 201 studies in normal subjects using gamma scintigraphy. Solutions, small pellets, and single units (matrix tablets and osmotic pumps) were administered with different amounts of food in the stomach, ranging from fasted state to heavy breakfast. Gastric emptying was affected by the nature of the dosage form and the presence of food in the stomach. Solutions and pellets were emptied even when the stomach was in the digestive mode, while single units were retained for long periods of time, depending on the size of the meal. In contrast, measured intestinal transit times were independent of the dosage form and fed state. The small intestinal transit time of about three hours (mean +/- 1 h SEM) has implications for the design of dosage forms for the sustained release of drugs in specific positions in the gastrointestinal tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Charman, W. N., Porter, C. J. H., Mithani, S., & Dressman, J. B. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960085v · Cited by 617
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Population-Based Mechanistic Prediction of Oral Drug Absorption
Jamei, M., Turner, D., Yang, J., Neuhoff, S., Polak, S., Rostami-Hodjegan, A., & Tucker, G. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9099-y · Cited by 452
Variation in Gastrointestinal Transit of Pharmaceutical Dosage Forms in Healthy Subjects
Coupe, A. J., Davis, S. S., & Wilding, I. R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015849700421 · Cited by 231
Self-citationHatton, G. B., Yadav, V., Basit, A. W., & Merchant, H. A. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24365 · Cited by 204
Sjögren, E., Thörn, H., & Tannergren, C. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00861 · Cited by 98
Novel Oral Drug Formulations: Their Potential in Modulating Adverse Effects
Florence, A. T., & Jani, P. U. (1994) · Drug Safety · doi:10.2165/00002018-199410030-00005 · Cited by 84
Friend (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00348.x · Cited by 75
Rao, K. A., Yazaki, E., Evans, D. F., & Carbon, R. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2003.006825 · Cited by 64
Hilton, N. P., Leach, N. K., Hilton, M. M., Sparks, S. A., & McNaughton, L. R. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04387-5 · Cited by 35
Arts, I. C., Coolen, E. J., Bours, M. J., Huyghebaert, N., Stuart, M. A. C., Bast, A., & Dagnelie, P. C. (2012) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-9-16 · Cited by 33
Quantitation of small intestinal permeability during normal human drug absorption
Levitt, D. G. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-34 · Cited by 32
Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments
Johannsson, G., Skrtic, S., Lennernäs, H., Quinkler, M., & Stewart, P. M. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.925865 · Cited by 21
Metadata
- Authors
- Davis, S. S., Hardy, J. G., & Fara, J. W.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1986-08
- Volume
- 27
- Issue
- 8
- Pages
- 886-892
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2085444179
- Cited by
- 853
- References
- 0
- FWCI
- 21.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
